We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PULM market cap is 7.3M. The company's latest EPS is USD -3.8663 and P/E is -0.53.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.84M | 1.75M | 2.2M | 5.89M | 1.55M |
| Operating Income | -3.99M | -3.94M | -2.23M | 747k | -5.9M |
| Net Income | -3.82M | -3.77M | -2.08M | 825k | -5.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.91M | 12.63M | 5.17M | 6.07M | 7.3M |
| Operating Income | -20.69M | -9.86M | -20.17M | -18.95M | -14.74M |
| Net Income | -20.6M | -19.31M | -23.37M | -18.84M | -14.12M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.39M | 36.77M | 33.96M | 30.39M | 15.78M |
| Total Liabilities | 7.94M | 16.89M | 15.96M | 11.37M | 2.47M |
| Total Equity | 23.45M | 19.88M | 18M | 19.02M | 13.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.1M | 38.17M | 58.82M | 40.95M | 33.96M |
| Total Liabilities | 25.08M | 15.03M | 11.37M | 9.84M | 15.96M |
| Total Equity | 11.02M | 23.14M | 47.45M | 31.11M | 18M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.83M | -13.97M | -15.99M | -2.72M | -6.4M |
| Investing | -58k | -371k | -676k | -154k | -398k |
| Financing | 53k | 53k | 53k | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 3.23M | -12.48M | -19.73M | -19.36M | -15.99M |
| Investing | -58k | -281k | -144k | -86k | -676k |
| Financing | 17.71M | 20.98M | 43.48M | 1.23M | 53k |
| Market Cap | 7.3M |
| Price to Earnings Ratio | -0.53 |
| Price to Sales Ratio | 1.03 |
| Price to Cash Ratio | 0.39 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 3.65M |
| Average Volume (1 week) | 9.1k |
| Average Volume (1 Month) | 11.16k |
| 52 Week Change | -2.67% |
| 52 Week High | 2.7499 |
| 52 Week Low | 1.55 |
| Spread (Intraday) | 0.04 (1.94%) |
| Company Name | Pulmatrix Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.pulmatrix.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
